rs10754210

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001994.3(F13B):​c.1739-2246C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.259 in 151,194 control chromosomes in the GnomAD database, including 5,484 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.26 ( 5484 hom., cov: 28)

Consequence

F13B
NM_001994.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0580

Publications

8 publications found
Variant links:
Genes affected
F13B (HGNC:3534): (coagulation factor XIII B chain) This gene encodes coagulation factor XIII B subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as a plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon activation by the cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. [provided by RefSeq, Jul 2008]
F13B Gene-Disease associations (from GenCC):
  • factor XIII, b subunit, deficiency of
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • congenital factor XIII deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.312 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001994.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F13B
NM_001994.3
MANE Select
c.1739-2246C>T
intron
N/ANP_001985.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F13B
ENST00000367412.2
TSL:1 MANE Select
c.1739-2246C>T
intron
N/AENSP00000356382.2
F13B
ENST00000649282.1
c.494-2246C>T
intron
N/AENSP00000497116.1
F13B
ENST00000490002.1
TSL:3
n.150-2246C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.259
AC:
39149
AN:
151074
Hom.:
5477
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.159
Gnomad AMI
AF:
0.493
Gnomad AMR
AF:
0.254
Gnomad ASJ
AF:
0.301
Gnomad EAS
AF:
0.130
Gnomad SAS
AF:
0.294
Gnomad FIN
AF:
0.307
Gnomad MID
AF:
0.312
Gnomad NFE
AF:
0.315
Gnomad OTH
AF:
0.260
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.259
AC:
39164
AN:
151194
Hom.:
5484
Cov.:
28
AF XY:
0.257
AC XY:
18947
AN XY:
73764
show subpopulations
African (AFR)
AF:
0.159
AC:
6545
AN:
41282
American (AMR)
AF:
0.254
AC:
3844
AN:
15158
Ashkenazi Jewish (ASJ)
AF:
0.301
AC:
1043
AN:
3462
East Asian (EAS)
AF:
0.129
AC:
648
AN:
5012
South Asian (SAS)
AF:
0.294
AC:
1400
AN:
4762
European-Finnish (FIN)
AF:
0.307
AC:
3207
AN:
10430
Middle Eastern (MID)
AF:
0.312
AC:
91
AN:
292
European-Non Finnish (NFE)
AF:
0.315
AC:
21385
AN:
67786
Other (OTH)
AF:
0.263
AC:
552
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1222
2444
3665
4887
6109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
416
832
1248
1664
2080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.304
Hom.:
28218
Bravo
AF:
0.251
Asia WGS
AF:
0.214
AC:
745
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
3.5
DANN
Benign
0.42
PhyloP100
0.058
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10754210; hg19: chr1-197012111; API